Moreover, a direct correlation between high MELK expression and malignancy grade has been reported in melanoma (Ryu et al., 2007), breast cancer (Pickard et al., 2009) and brain tumors (Marie et al., 2008; Nakano et al., 2008). The gene discussed is MELK; the disease is breast cancer.